These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 20687460

  • 21. Roflumilast: clinical benefit in patients suffering from COPD.
    Ulrik CS, Calverley PM.
    Clin Respir J; 2010 Oct; 4(4):197-201. PubMed ID: 20887341
    [Abstract] [Full Text] [Related]

  • 22. Roflumilast for COPD.
    Izquierdo JL, Aparicio J.
    Drugs Today (Barc); 2010 Nov; 46(11):823-31. PubMed ID: 21225021
    [Abstract] [Full Text] [Related]

  • 23. Roflumilast (Daliresp) for COPD.
    Med Lett Drugs Ther; 2011 Jul 25; 53(1369):59-60. PubMed ID: 21778965
    [No Abstract] [Full Text] [Related]

  • 24. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL.
    Rev Clin Esp; 2011 Mar 25; 211 Suppl 2():22-30. PubMed ID: 21596170
    [Abstract] [Full Text] [Related]

  • 25. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T.
    Tuberk Toraks; 2008 Mar 25; 56(4):472-84. PubMed ID: 19123088
    [Abstract] [Full Text] [Related]

  • 26. Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.
    Giembycz MA, Field SK.
    Drug Des Devel Ther; 2010 Jul 21; 4():147-58. PubMed ID: 20689641
    [Abstract] [Full Text] [Related]

  • 27. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lipworth BJ.
    Lancet; 2010 Jul 21; 365(9454):167-75. PubMed ID: 15639300
    [Abstract] [Full Text] [Related]

  • 28. Roflumilast in chronic obstructive pulmonary disease: evidence from large trials.
    Cazzola M, Picciolo S, Matera MG.
    Expert Opin Pharmacother; 2010 Feb 21; 11(3):441-9. PubMed ID: 20102307
    [Abstract] [Full Text] [Related]

  • 29. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD, Dai YR, Xu ZJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan 21; 27(1):57-9. PubMed ID: 14989829
    [No Abstract] [Full Text] [Related]

  • 30. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E, Strydom K, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, Bredenbröker D, Bardin PG.
    J Allergy Clin Immunol; 2005 Aug 21; 116(2):292-8. PubMed ID: 16083782
    [Abstract] [Full Text] [Related]

  • 31. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 32. [Clinical profile of roflumilast].
    Izquierdo Alonso JL.
    Arch Bronconeumol; 2010 Dec 08; 46 Suppl 10():25-32. PubMed ID: 21316553
    [Abstract] [Full Text] [Related]

  • 33. The potential role of racecadotril in the treatment of diarrhea associated with roflumilast.
    López-Campos JL, Gutiérrez C, Calero C.
    Arch Bronconeumol; 2012 Nov 08; 48(11):426. PubMed ID: 22560927
    [No Abstract] [Full Text] [Related]

  • 34. Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
    Mulhall AM, Droege CA, Ernst NE, Panos RJ, Zafar MA.
    Expert Opin Investig Drugs; 2015 Nov 08; 24(12):1597-611. PubMed ID: 26419847
    [Abstract] [Full Text] [Related]

  • 35. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):154-61. PubMed ID: 17463412
    [Abstract] [Full Text] [Related]

  • 36. Roflumilast: a selective phosphodiesterase 4 inhibitor.
    Christie P.
    Drugs Today (Barc); 2005 Oct 15; 41(10):667-75. PubMed ID: 16389409
    [Abstract] [Full Text] [Related]

  • 37. New therapeutic options in the management of COPD - focus on roflumilast.
    Antoniu SA.
    Int J Chron Obstruct Pulmon Dis; 2011 Oct 15; 6():147-55. PubMed ID: 21468165
    [Abstract] [Full Text] [Related]

  • 38. [Pulmonary medicine. Two new drugs for the treatment of COPD].
    Rochat T.
    Rev Med Suisse; 2011 Jan 19; 7(278):145-6, 148-9. PubMed ID: 21400948
    [Abstract] [Full Text] [Related]

  • 39. [Phosphodiesterase-4 inhibitors: a new target in treatment of COPD].
    Michels G, Erdmann E, Pfister R.
    Dtsch Med Wochenschr; 2011 Nov 19; 136(44):2267-70. PubMed ID: 22028292
    [Abstract] [Full Text] [Related]

  • 40. Roflumilast: A Review in COPD.
    Garnock-Jones KP.
    Drugs; 2015 Sep 19; 75(14):1645-56. PubMed ID: 26338438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.